Dr. Tessa L Holyoake - CML - Chronic Myeloid Leukemia

Professor of Experimental Haematology
Paul O'Gorman Leukaemia Research Centre,
Section of Experimental Haematology,
Faculty of Medicine,
University of Glasgow
Extract of Univ. Of Glasgow - Heamatology

ARTICLES

Professor Tessa Holyoake, hailed as one of the most exceptional scientists of her generation, lost her battle with breast cancer last week
September 7, 2017, GlasgowLive

Presentation of the RSE Royal Medals by Her Majesty the Queen 2017
August 14, 2017, Royal Society Edinburgh
 
The 2017 Rowley Prize is awarded to Professor Tessa Holyoake
2017, iCMLf

A trial looking at different ways of giving imatinib to people with CML (GIMI)
November 20, 2015, Cancer Research UK

Award for Glasgow cancer specialist
November 16, 2015,  BBC News

A trial of hydroxychloroquine with imatinib for chronic myeloid leukaemia (CHOICES)
January 15, 2015, Cancer Research UK

The anti-proliferative activity of kinase inhibitors in chronic myeloid leukaemia cells is mediated by FOXO transcription factors
2014, Stem Cells

p53 and c-Myc Are Critical Signaling Hubs That Maintain Chronic Myeloid Leukemia
November 15, 2013, Journal Blood

Fellowship honour for Professor Tessa Holyoake
May 9, 2013, University of Glasgow
​
A study looking at how nilotinib affects CYP enzymes in chronic myeloid leukaemia
March 1, 2013, Cancer Research UK

Glasgow Professor discusses about new approach for CML treatment at UK conference
March 31, 2011, News Medical

New approach to leukemia chemotherapy -- is a cure in sight?
March 30, 2011, ScienceDaily

Hydroxychloroquine for chronic myeloid leukemia: complete cure on the horizon?
2011, University of Glasgow

Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory
January 12, 2002, British Journal of haematology